| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/01/2010 | CN101818185A Purification process for bacterial cytolysin |
| 09/01/2010 | CN101818044A Organogel of dipeptide-like and preparation method thereof |
| 09/01/2010 | CN101817920A Triple-bond pendant-group aliphatic poly (ester-carbonic ester) and preparation method thereof |
| 09/01/2010 | CN101816801A Biomedical foams |
| 09/01/2010 | CN101816797A Gold nanoparticles used as medicament carrier and method for preparing same |
| 09/01/2010 | CN101816796A Chinese medicament five-feng amino acid nutritional plaster matrix and preparation of externally applied nutritional plaster of same |
| 09/01/2010 | CN101816795A Nanometer magnetic control throat anesthesia compound preparation and use thereof |
| 09/01/2010 | CN101816790A Spray for treating radioactive xerostomia and preparation method thereof |
| 09/01/2010 | CN101816787A An allergen dosage form |
| 09/01/2010 | CN101816781A Gene recombinant human Cu-Zn superoxide dismutase liposome enteric-coated capsule and preparation method thereof |
| 09/01/2010 | CN101816780A Injectable bone growth factor-carrying microspheres and preparation method thereof |
| 09/01/2010 | CN101816777A Novel Boanmycin composition and preparation method thereof |
| 09/01/2010 | CN101816744A Energy-saving and environmentally-friendly method for preparing garlic oil cyclodextrine inclusion compound |
| 09/01/2010 | CN101816722A Wash-free antipruritic antibacterial gel with Chinese medicament components and preparation method thereof |
| 09/01/2010 | CN101816693A Echinacea purpurea extract powder and preparation method and application thereof |
| 09/01/2010 | CN101816691A Gensenosides osmotic pump capsule and preparation method thereof |
| 09/01/2010 | CN101816690A Gensenoside double-layer osmotic pump tablet and preparation method thereof |
| 09/01/2010 | CN101816679A Film-forming type iodine disinfectant and preparation method thereof |
| 09/01/2010 | CN101816677A Foam type external skin sanitizer and preparation method thereof |
| 09/01/2010 | CN101816672A Composition containing roxithromycin and ambroxol and preparation method thereof |
| 09/01/2010 | CN101816663A Medicinal composition and injecta for curing avian toxoplasmosis, and preparation method thereof |
| 09/01/2010 | CN101816660A Anti-infective medicinal composition for injection and preparation method thereof |
| 09/01/2010 | CN101816654A Medicinal combination of nalmefene hydrochloride and polyvinyl pyrrolidone and preparation method thereof |
| 09/01/2010 | CN101816650A Ornidazole-sodium chloride combination and preparation method thereof |
| 09/01/2010 | CN101816645A Anti-influenza virus nasal mucosa absorbent and preparation method thereof |
| 09/01/2010 | CN101816644A Composition of taxol and phenylalanine and preparation method thereof |
| 09/01/2010 | CN101816640A Prasugrel liposome solid preparation |
| 09/01/2010 | CN101816639A Tablets of mosapride citrate and preparation method thereof |
| 09/01/2010 | CN101816638A Methods and formulations for modulating the human sexual response |
| 09/01/2010 | CN101816637A Leflunomide tablet preparation and preparation method thereof |
| 09/01/2010 | CN101816636A Isosorbide mononitrate freeze-dried power injection and preparation method thereof |
| 09/01/2010 | CN101816635A Cephalosporin suspension granule and preparation method thereof |
| 09/01/2010 | CN101816634A Technology for preparing bone growth factor carrying microsphere by using ultrasonic atomization method |
| 09/01/2010 | CN101816632A Composite functional liposome and preparation method and application thereof |
| 09/01/2010 | CN101816631A Liposome preparation for tumor therapeutic vaccine and preparation method thereof |
| 09/01/2010 | CN101816630A Uricase lipid nanoparticle and preparation method thereof |
| 09/01/2010 | CN101816629A Dual target liposome and preparation method and application thereof |
| 09/01/2010 | CN101816628A Gel taking 3belta, 12,13-trihydroxy-oleanane-28-methyl ester as active component |
| 09/01/2010 | CN101816627A Synergistic treatment type multi-material sustained-release eye drop and preparation method |
| 09/01/2010 | CN101455674B Halenia ellipitica D.Don. total di-phenylcumalin drop-pills for treating chronic hepatitis and preparation method thereof |
| 09/01/2010 | CN101264058B Huperzine A and its derivative or salts sustained-release nanometer granule and preparing method thereof |
| 09/01/2010 | CN101229372B Medicine compounds for treating hypertension |
| 09/01/2010 | CN101229233B Chinese traditional medicine preparation for antiatheroscloresis and liver-protection, and preparingng method thereof |
| 09/01/2010 | CN101209349B Application of carbon nano-tube as carrier in transferring anti-cancer medicine |
| 09/01/2010 | CN101206944B Method of preparing bioavailability water-based magnetofluid |
| 09/01/2010 | CN101204385B Child soluble amantadine hydrochloride soluble tablet |
| 09/01/2010 | CN101190177B Dectancyl partial film forming gel composition and uses thereof |
| 09/01/2010 | CN101172102B Water-solubility cozymase Q10 supermolecule composition and method for preparing the same |
| 09/01/2010 | CN101147726B Good stability chloromycetin eyedrop and preparation method thereof |
| 09/01/2010 | CN101023996B Chinese medicine for treating exogenous epidemic disease and anemopyretic cold |
| 09/01/2010 | CN101003607B Method for blocking out dendric macromolecule, closed dendric macromolecule and application |
| 08/31/2010 | US7786288 A binding site of the cystosolic protein cyclophilin A on human immunodeficiency virus capsid protein, which may be expressed by a recombinant viral, bacterial or yeast carrier; may be treated with neuraminidase or trypsin to remove sialic acid; immune stimulant such as teichoic acid or zymosan |
| 08/31/2010 | US7786279 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection |
| 08/31/2010 | US7786221 drug polymer conjugates comprising biomaterials such as proteins linked through an activated moiety to a water soluble polyoxyethylene glycol derivatives |
| 08/31/2010 | US7786213 Protein-polymer conjugate prepared by reacting a bromoisobutyrate-modified ligand initiator, such as biotin, with the protein to form initiator-modified locations on it, and polymerizing a monomer, such as N-isopropylacrylamide or methoxy(poly)oxyethylene methacrylate, to form the conjugate; streptavidin |
| 08/31/2010 | US7786174 Administering a compound that inhibits islet amyloid polypeptide-associated amyloid deposition, e.g., 8-hydroxy-5-quinolinesulfonic acid, sodium cyclohexylsulfamate, or octahydroisoquinolinyl-N-propanesulfonic acid; antidiabetic agents |
| 08/31/2010 | US7786172 percutaneously; cyclical mastalgia; may be formulated in a hydroalcoholic gel or an alcoholic solution |
| 08/31/2010 | US7786133 Chemically modified small molecules |
| 08/31/2010 | US7786119 Drug conjugates of ion channel modulating compounds |
| 08/31/2010 | US7786118 Temozolomide FDA Orange book listed patent; water soluble, and storage stable formulation; L-threonine as dissolution enhancer |
| 08/31/2010 | US7786102 Steroids as agonists for FXR |
| 08/31/2010 | US7786095 cyclodextrins; forming micelles or vesicles; used as hosts for the encapsulation, solubilization and/or stabilization of various compounds. |
| 08/31/2010 | US7786073 multicompartment; first compartment contains an aqueous medium, second compartment contains an ingredient that is stable when stored within the compartment; user can selectively mix the first and second mixture in first compartment; the aqueous medium after being combined is less stable |
| 08/31/2010 | US7785891 Perfusion blood through tube coated with collagen; measure thrombosis and platelet aggregation; prevent cardiovascular disorders |
| 08/31/2010 | US7785873 Antigen arrays for treatment of bone disease |
| 08/31/2010 | US7785817 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 08/31/2010 | US7785816 Antibodies against cancer antigen TMEFF2 and uses thereof |
| 08/31/2010 | US7785650 Water soluble, gelatin-free dip coatings for pharmaceutical solid dosage forms such as tablets comprising hydroxypropylmethyl cellulose and xanthan gum, carrageenan, and mixtures thereof, or hydroxypropylmethyl cellulose and castor oil or maltodextrin |
| 08/31/2010 | US7785639 Flavonoid isolated from Pteridophyta, Thelypteris torresiana; anticancer |
| 08/31/2010 | US7785632 angiogenesis inhibitors; tetraiodothyroacetic acid conjugated to glycolide-lactide copolymer; binds cell surface receptor for thyroid hormone on integrin alpha at cell membrane level and does not activate signal transduction |
| 08/31/2010 | US7785630 Mixture of active material in matrix of fatty alcohol or acid and solid hydrocarbon; microsphere |
| 08/31/2010 | US7785621 Oral compositions of fenretinide having increased bioavailability and methods of using the same |
| 08/31/2010 | US7785620 Cholesterol lowering and blood lipids lowering composition |
| 08/31/2010 | US7785619 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens |
| 08/31/2010 | US7785618 Conjugates comprising a biodegradable polymer and uses therefor |
| 08/31/2010 | US7785617 Usable both as a scaffold for the growth of new tissue and as a delivery system or implant for pharmaceuticals, vaccines, hormones enzymes, and nutrients; high strength bonding between cell-compatible crosslinkers, e.g., biotin and/or avidin, and polymer, e.g., polyglycolic acid; diffusion; shaping |
| 08/31/2010 | US7785610 Chimeric immunomodulatory compounds and methods of using the same—III |
| 08/31/2010 | US7785600 Compositions and methods for treating allergies, auto-immune diseases, and improving skin condition by ganoderma lucidum (reishi) polysaccharides |
| 08/31/2010 | US7785599 Albumin fusion proteins |
| 08/31/2010 | US7785592 Stabilized liquid anti-RSV antibody formulations |
| 08/31/2010 | US7785583 administering imiquimod and carrier to a site to induce local inflammation at the site, then administering antigen-loaded antigen presenting cells, to eliciting an immune response; immunology |
| 08/31/2010 | US7785577 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb |
| 08/31/2010 | US7785570 Combination vaccine for poultry |
| 08/31/2010 | CA2549383C Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof |
| 08/31/2010 | CA2473152C Orally dispersible pharmaceutical piribedil composition |
| 08/31/2010 | CA2462008C Systems, methods and apparatuses for manufacturing dosage forms |
| 08/26/2010 | WO2010096558A1 Bi-functional co-polymer use for ophthalmic and other topical and local applications |
| 08/26/2010 | WO2010096134A1 Extended length botulinum toxin formulation for human or mammalian use |
| 08/26/2010 | WO2010095940A2 Glutathione-based drug delivery system |
| 08/26/2010 | WO2010095912A2 Method for manufacturing non-soluble drug nanocomplex |
| 08/26/2010 | WO2010095578A1 Adhesive composition and adhesive tape |
| 08/26/2010 | WO2010095537A1 Transdermal preparation |
| 08/26/2010 | WO2010095494A1 Granules containing poorly soluble substance, tablet, and method for solubilizing poorly soluble substance |
| 08/26/2010 | WO2010095090A1 A dermaceutical gel made using sodium fusidate & a process to make it |
| 08/26/2010 | WO2010094906A1 The stabilisation of proteins |
| 08/26/2010 | WO2010094720A2 Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists |
| 08/26/2010 | WO2010094698A2 Switchable affinity binders |
| 08/26/2010 | WO2010094623A1 Formulation comprising drospirenone for subcutaneous or intramuscular administration |
| 08/26/2010 | WO2010094130A1 Carbohydrate-metallocene-antimalarial conjugates |
| 08/26/2010 | WO2010080720A3 Conjugates of a lysosomal enzyme moiety and a water soluble polymer |